Trial of Antibody Drug for COVID-19 Stopped for Lack of Effectiveness – Renal and Urology News
Eli Lilly says government is continuing a separate study testing the antibody drug in mild to moderately ill patients.
Related Articles
Enhertu Gets Accelerated Approval for HER2-Expressing Solid Tumors – Renal and Urology News
The approval was based on data from 3 clinical trials: DESTINY-PanTumor02, DESTINY-Lung01, and DESTINY-CRC02.
Worse Sepsis Outcomes Linked to Higher Pro- and Anti-Inflammatory Cytokine Levels – Renal and Urology News
Researchers identified inflammatory subgroups in sepsis and assessed their association with previously described transcriptomic subphenotypes.
AANA Issues Considerations for GLP-1 Receptor Agonist Use Before Surgery – Renal and Urology News
Considerations include holding medication on day or week of surgery/procedure in case of daily or weekly dose
HIF-PHI, ESA Have Similar Cardiovascular Safety Profiles – Renal and Urology News
Findings are based on a systematic review and meta-analysis of 25 trials involving 26,478 patients with chronic kidney disease (CKD) with or without dialysis.
Interstitial Cystitis Pain Eases More With Intravesical Interferon vs Hyaluronic Acid – Renal and Urology News
Although viral infection is a potential cause of painful interstitial cystitis, few previous studies have examined antiviral treatment.
Gram-Negative BSI: Initial Clinical Response to Therapy May Predict Complications – Renal and Urology News
Researchers assessed the incidence and predictors of complications in patients with gram-negative bloodstream infections.
Rusfertide Shows Promise in Polycythemia Vera – Renal and Urology News
Researchers sought to determine whether rusfertide would be effective in patients with polycythemia vera.
Causal Relationship Between Gut Microbial Genera and Risk for Hyperuricemia Confirmed – Renal and Urology News
Investigators assessed potential causal links between certain microbial genera and the risks for hyperuricemia and gout using Mendelian randomization methods.
Low Rates of Sustained Treatment Response in Lupus Nephritis Highlight Need for Improved Therapies – Renal and Urology News
Researchers assessed treatment response patterns and percentages over 52 weeks among patients with lupus nephritis receiving standard of care therapy.
Genetic Factors Influence Subsequent Cancer Risk in Childhood Cancer Survivors – Renal and Urology News
Examination of joint links between polygenic risk scores and radiotherapy show more than additive increases in risk for some cancers